Ignacio Santos Gil-rekin lankidetzan egindako argitalpenak (12)

2023

  1. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV

    Biomedicine and Pharmacotherapy, Vol. 162

  2. HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART

    Journal of Medical Virology, Vol. 95, Núm. 7

  3. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

    Journal of Molecular Medicine, Vol. 101, Núm. 11, pp. 1409-1420

2022

  1. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252

  2. Dynamics of HIV Reservoir and HIV‐1 Viral Splicing in HCV‐Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

    Biomedicine and Pharmacotherapy, Vol. 145

  4. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Different HCV exposure drives specific miRNA profile in PBMCS of HIV patients

    Biomedicines, Vol. 9, Núm. 11

2020

  1. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  2. Hepatitis C virus influences HIV-1 viral splicing in coinfected patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-18

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134